HIF-1 effects on angiogenic potential in human small cell lung carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Wan, Jun ^a   Chai, Huiping ^a   Yu, Zaicheng ^a   Ge, Wei ^a   Kang, Ningning ^a   Xia, Wanli ^a   Che, Yun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

angiogenesis; chick embryo chorioallantoic membrane; HIF 1; SCLC

Indexed keywords

COMPLEMENTARY DNA; FIBRONECTIN 1; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 28; PLATELET DERIVED GROWTH FACTOR C; PROTEIN; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 6; UNCLASSIFIED DRUG; VASCULOTROPIN A; HIF1A PROTEIN, HUMAN; MESSENGER RNA; TUMOR MARKER;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL TRANSPLANTATION; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG SMALL CELL CANCER; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; DNA MICROARRAY; ENZYME IMMUNOASSAY; GENE EXPRESSION PROFILING; GENETICS; LUNG TUMOR; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; VASCULARIZATION;

ANIMALS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; GENE EXPRESSION PROFILING; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMALL CELL LUNG CARCINOMA; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 80051600794     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-77     Document Type: Article

References (57)

1. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. GL Semenza, GL Wang, Mol Cell Biol 1992 12 5447 54 1448077
2. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. GL Wang, BH Jiang, EA Rue, GL Semenza, Proc Natl Acad Sci USA 1995 92 5510 4 10.1073/pnas.92.12.5510 7539918
3. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. H Zhong, AM De Marzo, E Laughner, M Lim, DA Hilton, D Zagzag, P Buechler, WB Isaacs, GL Semenza, JW Simons, Cancer Res 1999 59 5830 5 10582706
4. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. KL Talks, H Turley, KC Gatter, PH Maxwell, CW Pugh, PJ Ratcliffe, AL Harris, Am J Pathol 2000 157 411 21 10.1016/S0002-9440(10)64554-3 10934146 (Pubitemid 30626905)
5. Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. D Zagzag, H Zhong, JM Scalzitti, E Laughner, JW Simons, GL Semenza, Cancer 2000 88 2606 18 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W 10861440 (Pubitemid 30331970)
6. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. P Birner, M Schindl, A Obermair, C Plank, G Breitenecker, G Oberhuber, Cancer Res 2000 60 4693 6 10987269
7. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. P Carmeliet, Y Dor, JM Herbert, D Fukumura, K Brusselmans, M Dewerchin, M Neeman, F Bono, R Abramovitch, P Maxwell, CJ Koch, P Ratcliffe, L Moons, RK Jain, D Collen, E Keshert, Nature 1998 394 485 90 10.1038/28867 9697772 (Pubitemid 28373960)
8. Hypoxia-inducible factor-1 in human breast and prostate cancer. KS Kimbro, JW Simons, Endocr Relat Cancer 2006 13 739 49 10.1677/erc.1.00728 16954428 (Pubitemid 44763255)
9. Hypoxia-induced tumor angiogenic pathway in head and neck cancer: an in vivo study. PA Kyzas, D Stefanou, A Batistatou, NJ Agnantis, Cancer Lett 2005 225 297 304 10.1016/j.canlet.2004.11.060 15978334 (Pubitemid 40835878)
10. Hypoxia inducible factor-1 alpha and vascular endothelial growth factor in biopsies of small cell lung carcinoma. M Ioannou, R Papamichali, E Kouvaras, I Mylonis, D Vageli, T Kerenidou, S Barbanis, A Daponte, G Simos, K Gourgoulianis, GK Koukoulis, Lung 2009 187 321 9 10.1007/s00408-009-9169-z 19707816
11. Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1alpha activity and vascular endothelial growth factor expression in small cell lung cancer cells. J Litz, GW Krystal, Mol Cancer Ther 2006 5 1415 22 16818499 (Pubitemid 44070477)
12. Small cell lung carcinoma (SCLC): the angiogenic phenomenon. M Lucchi, A Mussi, G Fontanini, P Faviana, A Ribechini, CA Angeletti, Eur J Cardiothorac Surg 2002 21 1105 10 10.1016/S1010-7940(02)00112-4 12048093 (Pubitemid 34615629)
13. Tumor transplantation to the chick embryo. DA Karnofsky, LP Ridgway, PA Patterson, Ann NY Acad Sci 1952 55 313 29 10.1111/j.1749-6632.1952.tb26547.x 12977048
14. Invasion and Metastasis of Heterologous Tumors in the Chick Embryo. J Leighton, Prog Exp Tumor Res 1964 4 98 125 14150251
15. Determination of tumour prognosis based on angiogenesis-related vascular patterns measured by fractal and syntactic structure analysis. B Weyn, WA Tjalma, P Vermeylen, A van Daele, E Van Marck, W Jacob, Clin Oncol (R Coll Radiol) 2004 16 307 16 (Pubitemid 38696973)
16. Development of a computer-assisted high-throughput screening platform for anti-angiogenic testing. L Sanz, M Pascual, A Munoz, MA Gonzalez, CH Salvador, L Alvarez-Vallina, Microvasc Res 2002 63 335 9 10.1006/mvre.2001.2389 11969310 (Pubitemid 34971629)
17. Computer-supported angiogenesis quantification using image analysis and statistical averaging. CN Doukas, I Maglogiannis, AA Chatziioannou, IEEE Trans Inf Technol Biomed 2008 12 650 7 18779080
18. Development of a green fluorescent protein metastatic-cancer chick-embryo drug-screen model. V Bobek, J Plachy, D Pinterova, K Kolostova, M Boubelik, P Jiang, M Yang, RM Hoffman, Clin Exp Metastasis 2004 21 347 52 15554391 (Pubitemid 39434545)
19. Tumor cell intravasation alu-cidated: the chick embryo opens the window. JP Quigley, PB Armstrong, Cell 1998 94 281 4 10.1016/S0092-8674(00)81470-1 9708729 (Pubitemid 28376071)
20. An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells. D Mangieri, B Nico, AM Coluccia, A Vacca, M Ponzoni, D Ribatti, Cancer Lett 2009 277 199 204 10.1016/j.canlet.2008.12.014 19150583
21. Angiogenesis by transplantation of HIF-1 alpha modified EPCs into ischemic limbs. M Jiang, B Wang, C Wang, B He, H Fan, TB Guo, Q Shao, L Gao, Y Liu, J Cell Biochem 2008 103 321 34 10.1002/jcb.21416 17541946
22. In vivo enhancement of angiogenesis by adenoviral transfer of HIF-1alpha-modified endothelial progenitor cells (Ad-HIF-1alpha-modified EPC for angiogenesis). M Jiang, B Wang, C Wang, B He, H Fan, Q Shao, L Gao, Y Liu, G Yan, J Pu, Int J Biochem Cell Biol 2008 40 2284 95 10.1016/j.biocel.2008.03.012 18450499
23. The effects of HIF-1alpha on gene expression profiles of NCI-H446 human small cell lung cancer cells. J Wan, J Ma, J Mei, G Shan, J Exp Clin Cancer Res 2009 28 150 10.1186/1756-9966-28-150 20003295
24. Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transduction of human pancreatic cancer cells. E Toyoda, R Doi, K Kami, T Mori, D Ito, M Koizumi, A Kida, K Nagai, T Ito, T Masui, M Wada, M Tagawa, S Uemoto, Int J Oncol 2008 33 1141 7 19020746
25. Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells. M Miyagishi, M Hayashi, K Taira, Antisense Nucleic Acid Drug Dev 2003 13 1 7 10.1089/108729003764097296 12691531
26. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. DA Elson, HE Ryan, JW Snow, R Johnson, JM Arbeit, Cancer Res 2000 60 6189 95 11085544
27. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. HE Ryan, M Poloni, W McNulty, D Elson, M Gassmann, JM Arbeit, RS Johnson, Cancer Res 2000 60 4010 5 10945599 (Pubitemid 30636574)
28. Early steps in hematogenous metastasis of B16F1 melanoma cells in chick embryos studied by high-resolution intravital videomicroscopy. AF Chambers, EE Schmidt, IC MacDonald, VL Morris, AC Groom, J Natl Cancer Inst 1992 84 797 803 10.1093/jnci/84.10.797 1573668
29. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. PC Brooks, AM Montgomery, M Rosenfeld, RA Reisfeld, T Hu, G Klier, DA Cheresh, Cell 1994 79 1157 64 10.1016/0092-8674(94) 90007-8 7528107
30. Antineoplastic efficacy of doxorubicin enzymatically assembled on galactose residues of a monoclonal antibody specific for the carcinoembryonic antigen. AC Stan, DL Radu, S Casares, CA Bona, TD Brumeanu, Cancer Res 1999 59 115 21 9892195 (Pubitemid 29062966)
31. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I. MJ Chen, PP Chiou, P Lin, CM Lin, S Siri, K Peck, TT Chen, J Cell Biochem 2007 101 1316 27 10.1002/jcb.21254 17286280 (Pubitemid 47253729)
32. Chick embryo chorioallantoic membrane (CAM) model: a useful tool to study short-term transplantation of cryopreserved human ovarian tissue. B Martinez-Madrid, J Donnez, AS Van Eyck, A Veiga-Lopez, MM Dolmans, A Van Langendonckt, Fertil Steril 2009 91 285 92 10.1016/j.fertnstert.2007.11.026 18291379
33. SCID-hu mice for the study of human cancer metastasis. R Namikawa, E Shtivelman, Cancer Chemother Pharmacol 1999 43 Suppl 37 41
34. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. NJ Beasley, R Leek, M Alam, H Turley, GJ Cox, K Gatter, P Millard, S Fuggle, AL Harris, Cancer Res 2002 62 2493 7 11980639 (Pubitemid 34462724)
35. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. M Volm, R Koomagi, Anticancer Res 2000 20 1527 33 10928066 (Pubitemid 30628160)
36. Irinotecan (I), carboplatin (C), and radiotherapy (RT) followed by maintenance bevacizumab (B) in the treatment (tx) of limited-stage small cell lung cancer (LS-SCLC): Update of a phase II trial of the Minnie Pearl Cancer Research Network. JF Patton, DR Spigel, FA Greco, WH Liggett, JD Zubkus, M Baskette, M Schreeder, D Woytowitz, E Nelson, JD Hainsworth, Journal of Clinical Oncology 2006 24 385
37. Cediranib (AZD2171) for the treatment of recurrent small cell lung cancer (SCLC): A California Consortium phase II study (NCI # 7097). SS Ramalingam, PC Mack, EE Vokes, J Longmate, R Govindan, M Koczywas, SP Ivy, CP Belani, DR Gandara, J Clin Oncol 2008 26 443
38. Sorafenib in patients with platinum (plat) treated extensive stage small cell lung cancer (E-SCLC): A SWOG (S0435) phase II trial. BJ Gitlitz, BS Glisson, J Moon, H Reimers, DR Gandara, J Clin Oncol 2008 26 433
39. Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF. E Schipani, C Maes, G Carmeliet, GL Semenza, J Bone Miner Res 2009 24 1347 53 10.1359/jbmr.090602 19558314
40. The hypoxic response of tumors is dependent on their microenvironment. B Blouw, H Song, T Tihan, J Bosze, N Ferrara, HP Gerber, RS Johnson, G Bergers, Cancer Cell 2003 4 133 46 10.1016/S1535-6108(03)00194-6 12957288 (Pubitemid 37040829)
41. Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer. M Michael, B Babic, R Khokha, M Tsao, J Ho, M Pintilie, K Leco, D Chamberlain, FA Shepherd, J Clin Oncol 1999 17 1802 8 10561218 (Pubitemid 29269250)
42. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. FA Shepherd, G Giaccone, L Seymour, C Debruyne, A Bezjak, V Hirsh, M Smylie, S Rubin, H Martins, A Lamont, M Krzakowski, A Sadura, B Zee, J Clin Oncol 2002 20 4434 9 10.1200/JCO.2002.02.108 12431965 (Pubitemid 35334754)
43. Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J Lohi, CL Wilson, JD Roby, WC Parks, J Biol Chem 2001 276 10134 44 10.1074/jbc.M001599200 11121398
44. Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells. SA Illman, K Lehti, J Keski-Oja, J Lohi, J Cell Sci 2006 119 3856 65 10.1242/jcs.03157 16940349 (Pubitemid 44614437)
45. HIF-1alpha and cancer therapy. MY Koh, TR Spivak-Kroizman, G Powis, Recent Results Cancer Res 2010 180 15 34 10.1007/978-3-540-78281-0-3 20033376
46. Inhibition of angiogenesis via FGF-2 blockage in primitive and bone metastatic renal cell carcinoma. E Cenni, F Perut, D Granchi, S Avnet, I Amato, ML Brandi, A Giunti, N Baldini, Anticancer Res 2007 27 315 9 17352248
47. FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue. Y Xue, R Cao, D Nilsson, S Chen, R Westergren, EM Hedlund, C Martijn, L Rondahl, P Krauli, E Walum, S Enerback, Y Cao, Proc Natl Acad Sci USA 2008 105 10167 72 10.1073/pnas.0802486105 18621714
48. The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer. JL Boddy, SB Fox, C Han, L Campo, H Turley, S Kanga, PR Malone, AL Harris, Clin Cancer Res 2005 11 7658 63 10.1158/1078-0432.CCR-05-0460 16278385 (Pubitemid 41611607)
49. Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14. HG Wisniewski, J Vilcek, Cytokine Growth Factor Rev 2004 15 129 46 10.1016/j.cytogfr.2004.01.005 15110797 (Pubitemid 38521249)
50. Interleukin 1 regulates its own receptors in human endometrial cells via distinct mechanisms. C Bellehumeur, J Blanchet, JY Fontaine, N Bourcier, A Akoum, Hum Reprod 2009 24 2193 204 10.1093/humrep/dep192 19477877
51. Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness. A Saidi, M Hagedorn, N Allain, C Verpelli, C Sala, L Bello, A Bikfalvi, S Javerzat, Int J Cancer 2009 125 1054 64 10.1002/ijc.24380 19431143
52. Tumor inflammatory angiogenesis and its chemoprevention. A Albini, F Tosetti, R Benelli, DM Noonan, Cancer Res 2005 65 10637 41 10.1158/0008-5472. CAN-05-3473 16322203 (Pubitemid 41713327)
53. Tenascin-C is associated with coronary plaque instability in patients with acute coronary syndromes. K Kenji, U Hironori, Y Hideya, I Michinori, H Yasuhiko, K Nobuoki, Circ J 2004 68 198 203 10.1253/circj.68.198 14993772 (Pubitemid 38405009)
54. Molecular basis of angiogenesis and cancer. T Tonini, F Rossi, PP Claudio, Oncogene 2003 22 6549 56 10.1038/sj.onc.1206816 14528279 (Pubitemid 37372334)
55. Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice. G Sass, P Leukel, V Schmitz, E Raskopf, M Ocker, D Neureiter, M Meissnitzer, E Tasika, A Tannapfel, G Tiegs, Int J Cancer 2008 123 1269 77 10.1002/ijc.23695 18566988
56. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. M Sunamura, DG Duda, MH Ghattas, L Lozonschi, F Motoi, J Yamauchi, S Matsuno, S Shibahara, NG Abraham, Angiogenesis 2003 6 15 24 10.1023/A: 1025803600840 14517400 (Pubitemid 37305335)
57. Co-expression of thymidine phosphorylase and heme oxygenase-1 in macrophages in human malignant vertical growth melanomas. H Torisu-Itakura, M Furue, M Kuwano, M Ono, Jpn J Cancer Res 2000 91 906 10 11011118